A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Janssen Research & Development, LLC
Start Date
February 12, 2018
End Date
April 10, 2023
Administered By
Duke Clinical Research Institute
Awarded By
Janssen Research & Development, LLC
Start Date
February 12, 2018
End Date
April 10, 2023